ArticleFrontiers in pharmacology2026

Efficacy and safety of camrelizumab-based regimens in advanced squamous cell carcinoma patients: a prospective multicenter study.

Weijia Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.